| 英文品名 |
alacizumab pegol |
| 名称来源 |
p-INNList-98,2007;r-INNList-60,2008; |
| 化学表述 |
immunoglobulin di-Fab'fragment, anti-[Homo sapiens VEGFR2 (vascular endothelial growth factor receptor 2, KDR, kinase insert domain receptor, FLK1, CD309)] pegylated humanized monoclonal antibody di-Fab’ CDP791 (or g165 DFM-PEG); VH-gamma1CH1 [humanized VH (Homo sapiens FR/Mus musculus CDR) [8.8.10]-Homo sapiens IGHG1*01 CH1-hinge (hinge PPCP12-5>AA)] (220-214')-disulfide with kappa light chain [humanized V-KAPPA (Homo sapiens FR/Mus musculus CDR) [6.3.9] -Homo sapiens IGKC*01]; (226-bis-[maleimide-PEG (polyethylene glycol) 20 kDa]-226'')-dimer |
| CA登记号 |
934216-54-3 |
| 结 构 式 |
|
| 品种类别 |
antineoplastic; |
|
